Revitope Oncology, Inc.
PrivateLast Round
Strategic
Dec 15, 2020
Est. Valuation
$101M
Total Funding Raised
$18.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Revitope Oncology, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Strategic round in December 2020.
Revitope Oncology, Inc. is a biotechnology company that develops next-generation T-cell engager immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revitope Oncology, Inc. Comparables
Compare Revitope Oncology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clasp Therapeutics | 84% | |
| Amberstone Biosciences | 84% | |
| Cartography Biosciences | 80% |
For institutional investors. Book with your work email.
Revitope Oncology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 15, 2020 | ||||
| Series A | Feb 8, 2016 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 471% MoM, from 178 to 1K.
- Nov 9, 2025
Monthly visitors increased 305% MoM.
For institutional investors. Book with your work email.
Revitope Oncology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Revitope Oncology, Inc.'s valuation, stock price, and market status.
Is Revitope Oncology, Inc. a public or private company?
Revitope Oncology, Inc. is a private company.
What is the current stock price of Revitope Oncology, Inc.?
Revitope Oncology, Inc. is a private company, so its shares have no public market price. Caplight tracks Revitope Oncology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Revitope Oncology, Inc. worth (valuation)?
Revitope Oncology, Inc.'s valuation is estimated at $101.0M based on funding round data.
Can I buy Revitope Oncology, Inc. stock?
Revitope Oncology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Revitope Oncology, Inc.'s last funding round?
Revitope Oncology, Inc.'s most recent funding round was Strategic on December 15, 2020.
Who are the main investors in Revitope Oncology, Inc.?
Investor information for Revitope Oncology, Inc. is not publicly disclosed.
Will Revitope Oncology, Inc. IPO soon?
No public IPO plans have been announced for Revitope Oncology, Inc..
How can I track Revitope Oncology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Revitope Oncology, Inc.'s shares on secondary markets.